Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells

Overview of attention for article published in European Journal of Cancer (1965), July 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 15 patents

peer_reviews: 1 peer review site

Readers on

mendeley: 46 Mendeley

So far, Altmetric has seen 15 patents that reference this research output.

Pharmaceutical combination of anti CEACAM6 and TIM3 antibodies

Grant US-12221479-B2

United States of America

11 Feb 2025

BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND TUMOR ANTIGENS, AND…

Application EP-4389226-A2

European Patent Office

26 Jun 2024

Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and…

Grant US-11942149-B2

United States of America

26 Mar 2024

Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

Grant US-11840571-B2

United States of America

12 Dec 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 11 additional patents.